Nofima Mat AS   Report issue

For profit Phase 3
Founded: Tromso Norway (2008)

Organization Overview

First Clinical Trial
2011
NCT01568983
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Nofima | NOFIMA

Active Ingredients

Drugs in Phase 3 Trials (1)

mana-juice (1 trial)

Drugs in Other Trials (6)

apple (1 trial)

beta-glucans (2 trials)

cod (1 trial)

cod protein (3 trials)

egg (1 trial)

water soluble cod protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 3)

Prehypertension (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 7